Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy

Elena Ortona, Walter Malorni

Source: Eur Respir J, 59 (2) 2102245; 10.1183/13993003.02245-2021
Journal Issue: February

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Elena Ortona, Walter Malorni. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. Eur Respir J, 59 (2) 2102245; 10.1183/13993003.02245-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD mechanisms: novel aspects and implications for new therapies
Source: ERS Live 2007
Year: 2007


Underlying mechanisms and pharmacological approaches for treatment of sarcopenia
Source: Virtual Congress 2021 – Sarcopenia in chronic respiratory disease: new definitions, assessment and treatment options
Year: 2021


When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021
Year: 2021



Respiratory monitoring: revisiting classical physiological principles with new tools
Source: Eur Respir J 2004; 24 : 718-719
Year: 2004


Addressing unmet needs in understanding asthma mechanisms
Source: Eur Respir J, 49 (5) 1602448; 10.1183/13993003.02448-2016
Year: 2017



Exploring new frontiers: the role of simulation as an educational strategy
Source: Breathe 2013; 9: 497-501
Year: 2013

Fitness for radical treatment modalities: efficient functional assessment, improving fitness and fitness-adapted therapy concepts including the elderly
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017


A study of organizational effectiveness: identifying variables that predict successful respiratory therapy education programs
Source: Annual Congress 2006 - Assessments of impairment in adults and children, and airway clearance techniques
Year: 2006

TB following targeted and biological therapy: can we predict it?
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020


What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis
Source: Eur Respir Monogr 2018; 82: 414-429
Year: 2018


Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies?
Source: Eur Respir J, 59 (2) 2102417; 10.1183/13993003.02417-2021
Year: 2022



To explore mechanisms in obesity-associated asthma using functional proteomics technology: A pilot study
Source: International Congress 2017 – Novel mechanisms in asthma
Year: 2017

COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness
Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020
Year: 2020



What are the main mechanisms of oncogenic addiction?
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019


Molecular and genetic mechanisms in gender issues
Source: Virtual Congress 2021 – Highlights on gender and respiratory health
Year: 2021